Risk Factors for Skeletal Related Events in Breast Cancer Patients Receiving Bisphosphonates for Bone Metastases
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Bone Metastases|Breast Cancer
Sponsor: University Health Network, Toronto
Collaborators: AstraZeneca